Webinar on reflection paper on the qualification of non-mutagenic impurities, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 March 2025, 13:00 (CET) to 6 March 2025, 15:30 (CET)

Submitted by Anonymous (not verified) on 25 March 2025 - 10:53

Webinar on reflection paper on the qualification of non-mutagenic impurities, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 March 2025, 13:00 (CET) to 6 March 2025, 15:30 (CET)

EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 October 2025, 10:00 (CEST) to 9 October 2025, 16:10 (CEST)

Submitted by Anonymous (not verified) on 25 March 2025 - 10:24

EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 October 2025, 10:00 (CEST) to 9 October 2025, 16:10 (CEST)

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0038/2024

Submitted by Anonymous (not verified) on 25 March 2025 - 8:30

Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0038/2024

Opinion/decision on a Paediatric investigation plan (PIP): Exparel liposomal, bupivacaine, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pain, PIP number: P/0021/2024

Submitted by Anonymous (not verified) on 24 March 2025 - 16:00

Opinion/decision on a Paediatric investigation plan (PIP): Exparel liposomal, bupivacaine, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pain, PIP number: P/0021/2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More